Tag: Non drug treatment

While many people associate FDA approval with new drugs, Osteoboost is not a medication but a wearable medical device. In early 2024, the U.S. Food and Drug Administration granted it clearance through the De Novo pathway, a distinct regulatory process from that for pharmacological agents.

Clinical studies have consistently found rhinophototherapy, such as Rhinolight, to be a safe and well-tolerated treatment option for allergic rhinitis. This minimal risk profile is a significant advantage, particularly for those concerned about what are the side effects of Rhinolight compared to traditional medications like steroids and antihistamines. The most commonly reported side effects are minor and temporary.